Estimating time to ESRD using kidney failure risk equations: Results from the African American Study of Kidney Disease and Hypertension (AASK)

American Journal of Kidney Diseases

Volumn 65, Issue 3, 2015, Pages 394-402

  Grams, Morgan E ^a,b,c   Li, Liang ^d   Greene, Tom H ^e   Tin, Adrienne ^b   Sang, Yingying ^b   Kao, W H Linda ^b,c   Lipkowitz, Michael S ^f   Wright, Jackson T ^g   Chang, Alex R ^h   Astor, Brad C ⁱ   Appel, Lawrence J ^a,b,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h GEISINGER HEALTH SYSTEM   (United States)

ⁱ UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

African American Study of Kidney Disease and Hypertension (AASK); clinical decision making; disease progression; disease trajectory; End stage renal disease (ESRD); estimated glomerular filtration rate (eGFR); hypertensive kidney disease; kidney failure risk equations; prognosis; proteinuria; risk

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URINE PROTEIN CREATININE RATIO; CLINICAL TRIAL; DISEASE COURSE; ETHNOLOGY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RENAL INSUFFICIENCY;

ADULT; AFRICAN AMERICANS; AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RISK FACTORS;

EID: 84924064956     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.07.026     Document Type: Article

References (41)

1. T.P. Alves, X. Wang, and J.T. Wright Jr. Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis J Am Soc Nephrol 21 2010 1361 1369
2. R.T. Gansevoort, K. Matsushita, and M. van der Velde Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts Kidney Int 80 2011 93 104
3. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
4. A. Ishani, G.A. Grandits, and R.H. Grimm Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the Multiple Risk Factor Intervention Trial J Am Soc Nephrol 17 2006 1444 1452
5. D.S. Keith, G.A. Nichols, C.M. Gullion, J.B. Brown, and D.H. Smith Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 2004 659 663
6. K. Matsushita, M. van der Velde, and B.C. Astor Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073 2081
7. E.S. Johnson, M.L. Thorp, R.W. Platt, and D.H. Smith Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study Am J Kidney Dis 52 2008 653 660
8. S.K. Akkina, J.J. Connaire, J.J. Snyder, A.J. Matas, and B.L. Kasiske Earlier is not necessarily better in preemptive kidney transplantation Am J Transplant 8 2008 2071 2076
9. M.E. Grams, A.B. Massie, J. Coresh, and D.L. Segev Trends in the timing of pre-emptive kidney transplantation J Am Soc Nephrol 22 2011 1615 1620
10. A. Ishani, H.N. Ibrahim, D. Gilbertson, and A.J. Collins The impact of residual renal function on graft and patient survival rates in recipients of preemptive renal transplants Am J Kidney Dis 42 2003 1275 1282
11. Kidney Disease: Improving Global Outcomes. Clinical practice guideline for the evaluation and management of chronic kidney disease Kidney Int Suppl 3 2013 1 150
12. S.J. Barbour, L. Er, O. Djurdjev, M. Karim, and A. Levin Differences in progression of CKD and mortality amongst Caucasian, Oriental Asian and South Asian CKD patients Nephrol Dial Transplant 25 2010 3663 3672
13. A.I. Choi, R.A. Rodriguez, P. Bacchetti, D. Bertenthal, G.T. Hernandez, and A.M. O'Hare White/black racial differences in risk of end-stage renal disease and death Am J Med 122 2009 672 678
14. M. Evans, J.P. Fryzek, and C.G. Elinder The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden Am J Kidney Dis 46 2005 863 870
15. R. Hanratty, M. Chonchol, and L. Miriam Dickinson Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension Nephrol Dial Transplant 25 2010 801 807
16. K. Iseki, C. Iseki, Y. Ikemiya, and K. Fukiyama Risk of developing end-stage renal disease in a cohort of mass screening Kidney Int 49 1996 800 805
17. T.H. Jafar, C.H. Schmid, and P.C. Stark The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis Nephrol Dial Transplant 18 2003 2047 2053
18. M. Nakayama, T. Sato, and H. Sato Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: the Gonryo study Clin Exp Nephrol 14 2010 333 339
19. J. Neugarten, A. Acharya, and S.R. Silbiger Effect of gender on the progression of nondiabetic renal disease: a meta-analysis J Am Soc Nephrol 11 2000 319 329
20. A.M. O'Hare, A.I. Choi, and D. Bertenthal Age affects outcomes in chronic kidney disease J Am Soc Nephrol 18 2007 2758 2765
21. M. van der Velde, S.J. Bakker, P.E. de Jong, and R.T. Gansevoort Influence of age and measure of eGFR on the association between renal function and cardiovascular events Clin J Am Soc Nephrol 5 2010 2053 2059
22. J.L. Xue, P.W. Eggers, L.Y. Agodoa, R.N. Foley, and A.J. Collins Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged Medicare beneficiaries J Am Soc Nephrol 18 2007 1299 1306
23. C.R. Elley, E. Robinson, T. Kenealy, D. Bramley, and P.L. Drury Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the New Zealand Diabetes Cohort Study Diabetes Care 33 2010 1347 1352
24. N. Tangri, L.A. Stevens, and J. Griffith A predictive model for progression of chronic kidney disease to kidney failure JAMA 305 2011 1553 1559
25. M. Sika, J. Lewis, and J. Douglas Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) clinical trial and cohort study Am J Kidney Dis 50 2007 78 89 89.e71
26. L.J. Appel, J. Middleton, and E.R. Miller III The rationale and design of the AASK cohort study J Am Soc Nephrol 14 2003 S166 S172
27. S. Purcell, B. Neale, and K. Todd-Brown PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575
28. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
29. M.E. Grams, B.C. Astor, L.D. Bash, K. Matsushita, Y. Wang, and J. Coresh Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury J Am Soc Nephrol 21 2010 1757 1764
30. L. Li, B.C. Astor, and J. Lewis Longitudinal progression trajectory of GFR among patients with CKD Am J Kidney Dis 59 2012 504 512
31. M.E. Grams, J. Coresh, D.L. Segev, L.M. Kucirka, H. Tighiouart, and M.J. Sarnak Vascular disease, ESRD, and death: interpreting competing risk analyses Clin J Am Soc Nephrol 7 2012 1606 1614
32. A.M. O'Hare, A. Batten, and N.R. Burrows Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis Am J Kidney Dis 59 2012 513 522
33. S.J. Rosansky, W.F. Clark, P. Eggers, and R.J. Glassock Initiation of dialysis at higher GFRs: is the apparent rising tide of early dialysis harmful or helpful? Kidney Int 76 2009 257 261
34. R.B. D'Agostino Sr., R.S. Vasan, and M.J. Pencina General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753
35. N.J. Stone, J. Robinson, and A.H. Lichtenstein 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 pt B 2014 2889 2934
36. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
37. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
38. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
39. M.C. Foster, J. Coresh, and M. Fornage APOL1 variants associate with increased risk of CKD among African Americans J Am Soc Nephrol 24 2013 1484 1491
40. Z. Kanji, C.E. Powe, and J.B. Wenger Genetic variation in APOL1 associates with younger age at hemodialysis initiation J Am Soc Nephrol 22 2011 2091 2097
41. A. Parsa, W.H. Kao, and D. Xie APOL1 risk variants, race, and progression of chronic kidney disease N Engl J Med 369 2013 2183 2196